全文获取类型
收费全文 | 368353篇 |
免费 | 58646篇 |
国内免费 | 9087篇 |
专业分类
耳鼻咽喉 | 4094篇 |
儿科学 | 8668篇 |
妇产科学 | 3251篇 |
基础医学 | 56481篇 |
口腔科学 | 11762篇 |
临床医学 | 35009篇 |
内科学 | 70431篇 |
皮肤病学 | 7014篇 |
神经病学 | 35399篇 |
特种医学 | 20192篇 |
外国民族医学 | 81篇 |
外科学 | 34161篇 |
综合类 | 35014篇 |
现状与发展 | 26篇 |
一般理论 | 14篇 |
预防医学 | 20781篇 |
眼科学 | 6603篇 |
药学 | 44327篇 |
65篇 | |
中国医学 | 10764篇 |
肿瘤学 | 31949篇 |
出版年
2024年 | 740篇 |
2023年 | 5291篇 |
2022年 | 11374篇 |
2021年 | 15152篇 |
2020年 | 15648篇 |
2019年 | 19476篇 |
2018年 | 18619篇 |
2017年 | 19456篇 |
2016年 | 18563篇 |
2015年 | 19847篇 |
2014年 | 25714篇 |
2013年 | 26804篇 |
2012年 | 24064篇 |
2011年 | 26115篇 |
2010年 | 22023篇 |
2009年 | 19206篇 |
2008年 | 19515篇 |
2007年 | 17140篇 |
2006年 | 15416篇 |
2005年 | 13654篇 |
2004年 | 12014篇 |
2003年 | 10602篇 |
2002年 | 8835篇 |
2001年 | 7248篇 |
2000年 | 5621篇 |
1999年 | 3923篇 |
1998年 | 3454篇 |
1997年 | 3337篇 |
1996年 | 2963篇 |
1995年 | 2630篇 |
1994年 | 2429篇 |
1993年 | 2027篇 |
1992年 | 1738篇 |
1991年 | 1637篇 |
1990年 | 1385篇 |
1989年 | 1222篇 |
1988年 | 1138篇 |
1987年 | 1005篇 |
1986年 | 916篇 |
1985年 | 1334篇 |
1984年 | 1284篇 |
1983年 | 896篇 |
1982年 | 957篇 |
1981年 | 765篇 |
1980年 | 682篇 |
1979年 | 537篇 |
1978年 | 370篇 |
1977年 | 322篇 |
1976年 | 277篇 |
1975年 | 180篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
21.
《Journal of vascular and interventional radiology : JVIR》2022,33(6):660-667
PurposeTo investigate the safety and efficacy of an aqueous polyethylene glycol-based liquid embolic agent, Embrace Hydrogel Embolic System (HES), in the treatment of benign and malignant hypervascular tumors.Materials and MethodsA prospective, single-arm, multicenter study included 8 patients, 5 males and 3 females, with a median age of 58.5 years (30–85 years), who underwent embolization in 8 tumors between October 2019 and May 2020. Technical success was defined as successful delivery of HES to the index vessel, with disappearance of >90% of the targeted vascular enhancement or, for portal vein embolization, occlusion of the portal branches to the liver segments for future resection. The volume of HES administered, ease of use (5 point Likert scale), administration time, and adverse events (AEs) were recorded. Evaluation was performed at 7, 30, and 90 days via clinical assessment and blood testing, and follow-up imaging was performed at 30 days.ResultsEight patients were enrolled, and 10 embolizations were performed in 8 lesions. Tumors included hepatocellular carcinoma (n = 4), renal angiomyolipoma (n = 3), and intrahepatic cholangiocarcinoma (n = 1). Technical success was 100%, and the average ease of use was 3.3 ± 1.0 SD. The HES delivery time was 1–28 minutes (median, 16.5 minutes), and the HES volume injected was 0.4–4.0 mL (median, 1.3 mL). All patients reached 30-day follow-up with imaging, and 6 patients reached 90-day follow-up. There were 3 serious AEs in 2 patients that were unrelated to the embolic agent.ConclusionHES resulted in a 100% embolization technical success rate. The product ease of use was acceptable, and no target vessel recanalization was noted on follow-up imaging at 30 days. 相似文献
22.
《The Journal for Nurse Practitioners》2022,18(2):245-247
Transient stress hyperglycemia in the setting of acute myocardial infarction is a frequent phenomenon. Its transient nature should not dissuade the clinician from management of elevated blood glucose in a patient after an ST-elevation myocardial infarction. This case presents an adult patient after an ST-elevation myocardial infarction with transient stress hyperglycemia and the evidence used to identify optimal pharmacologic management and secondary prevention. 相似文献
23.
Lipid nanoparticles (LNPs) are becoming popular as a means of delivering therapeutics, including those based on nucleic acids and mRNA. The mRNA-based coronavirus disease 2019 vaccines are perfect examples to highlight the role played by drug delivery systems in advancing human health. The fundamentals of LNPs for the delivery of nucleic acid- and mRNA-based therapeutics, are well established. Thus, future research on LNPs will focus on addressing the following: expanding the scope of drug delivery to different constituents of the human body, expanding the number of diseases that can be targeted, and studying the change in the pharmacokinetics of LNPs under physiological and pathological conditions. This review article provides an overview of recent advances aimed at expanding the application of LNPs, focusing on the pharmacokinetics and advantages of LNPs. In addition, analytical techniques, library construction and screening, rational design, active targeting, and applicability to gene editing therapy have also been discussed. 相似文献
24.
25.
26.
Phoebe Hammer Kevin White Stephanie Mengden Vessy Korcheva Philipp W. Raess 《Journal of cutaneous pathology》2019,46(5):343-346
Cutaneous leiomyomas are rare benign smooth‐muscle tumors. These lesions are distinguished based on their cell of origin and are subclassified as pilar leiomyoma, angioleiomyoma, and genital‐type leiomyoma. Nipple leiomyoma is the least common genital‐type leiomyoma, arising from the dartoic muscle cell of the nipple. Histologic examination of the lesion is necessary for definitive diagnosis, and these uncommon tumors can pose a diagnostic challenge. We describe herein a series of six nipple leiomyomas with a spectrum of histologic appearances. 相似文献
27.
28.
29.
30.